Cost–effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costs
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cost–effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costs
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 13, Issue 12, Pages 1405-1417
Publisher
Future Medicine Ltd
Online
2012-09-12
DOI
10.2217/pgs.12.124
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The effectiveness and cost-effectiveness of biomarkers for the prioritisation of patients awaiting coronary revascularisation: a systematic review and decision model
- (2014) H Hemingway et al. HEALTH TECHNOLOGY ASSESSMENT
- Cost-Effectiveness of Using Pharmacogenetic Information in Warfarin Dosing for Patients With Nonvalvular Atrial Fibrillation
- (2013) Mark H. Eckman ANNALS OF INTERNAL MEDICINE
- Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation
- (2012) Leif Friberg et al. CIRCULATION
- Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation
- (2012) Anuraag R Kansal et al. HEART
- Cost-Effectiveness of Dabigatran versus Genotype-Guided Management of Warfarin Therapy for Stroke Prevention in Patients with Atrial Fibrillation
- (2012) Joyce H. S. You et al. PLoS One
- Statistical design of personalized medicine interventions: The Clarification of Optimal Anticoagulation through Genetics (COAG) trial
- (2012) Benjamin French et al. Trials
- Cost-Effectiveness of Dabigatran for Stroke Prophylaxis in Atrial Fibrillation
- (2011) Shimoli V. Shah et al. CIRCULATION
- Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA
- (2011) M. Wieloch et al. EUROPEAN HEART JOURNAL
- Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data
- (2011) Rianne M.F. van Schie et al. EUROPEAN HEART JOURNAL
- Drug interactions with phenprocoumon and the risk of serious haemorrhage: a nested case–control study in a large population-based German database
- (2011) Kathrin Jobski et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data
- (2011) Carl Heneghan et al. LANCET
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost Effectiveness of Warfarin Versus Aspirin in Patients Older Than 75 Years With Atrial Fibrillation
- (2011) Sue Jowett et al. STROKE
- Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients
- (2011) Arlene Gallagher et al. THROMBOSIS AND HAEMOSTASIS
- Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation
- (2011) Marcus Lind et al. THROMBOSIS RESEARCH
- Planning and monitoring of patients for electrical cardioversion for atrial fibrillation
- (2011) J. H. H. Deuling et al. Netherlands Heart Journal
- Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial
- (2010) Lars Wallentin et al. LANCET
- Risk of intracerebral hemorrhage associated with phenprocoumon exposure: a nested case-control study in a large population-based German database
- (2010) Sigrid Behr et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- A systematic review of cost–effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivatives
- (2010) Talitha I Verhoef et al. PHARMACOGENOMICS
- Cost-effectiveness of genotype-guided warfarin therapy for anticoagulation in elderly patients with atrial fibrillation
- (2009) Julio A. Leey et al. American Journal Geriatric Pharmacotherapy
- Thrombomodulin as a Marker for Bleeding Complications During Warfarin Treatment
- (2009) Marcus Lind et al. ARCHIVES OF INTERNAL MEDICINE
- Optimal Level of Oral Anticoagulant Therapy for the Prevention of Arterial Thrombosis in Patients With Mechanical Heart Valve Prostheses, Atrial Fibrillation, or Myocardial Infarction
- (2009) Marieke Torn et al. ARCHIVES OF INTERNAL MEDICINE
- Cost-Effectiveness of Genotype-Guided Warfarin Dosing for Patients With Atrial Fibrillation
- (2009) Amanda R. Patrick et al.
- Potential Clinical and Economic Outcomes of CYP2C9 and VKORC1 Genotype-Guided Dosing in Patients Starting Warfarin Therapy
- (2009) J H S You et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenetics of Oral Anticoagulant Therapy
- (2009) T. Schalekamp et al. CURRENT PHARMACEUTICAL DESIGN
- International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness?
- (2009) Takeru Shiroiwa et al. HEALTH ECONOMICS
- Self-monitoring of oral anticoagulation: does it work outside trial conditions?
- (2009) C Gardiner et al. JOURNAL OF CLINICAL PATHOLOGY
- Cost-effectiveness of ruling out deep venous thrombosis in primary care versus care as usual
- (2009) A. J. TEN CATE-HOEK et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Is patient self-testing a good thing?
- (2009) Lynn B. Oertel et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic and environmental factors determining clinical outcomes and cost of warfarin therapy: a prospective study
- (2009) Andrea L. Jorgensen et al. Pharmacogenetics and Genomics
- Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design
- (2009) Rianne MF van Schie et al. PHARMACOGENOMICS
- In-hospital direct cost of acute ischemic and hemorrhagic stroke in Greece
- (2008) G. Gioldasis et al. ACTA NEUROLOGICA SCANDINAVICA
- Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme
- (2008) Stephan Rietbrock et al. AMERICAN HEART JOURNAL
- Pharmacology and Management of the Vitamin K Antagonists
- (2008) Jack Ansell et al. CHEST
- Healthcare impact of personalized medicine using genetic testing: an exploratory analysis for warfarin
- (2008) Andrew McWilliam et al. Personalized Medicine
- VKORC1andCYP2C9allelic variants influence acenocoumarol dose requirements in Greek patients
- (2008) Christos N Markatos et al. PHARMACOGENOMICS
- The Costs of Care in Atrial Fibrillation and the Effect of Treatment Modalities in Germany
- (2008) Doreen McBride et al. VALUE IN HEALTH
- Quality of Anticoagulation Monitoring in Nonvalvular Atrial Fibrillation Patients: Comparison of Anticoagulation Clinic versus Usual Care
- (2007) Michael B Nichol et al. ANNALS OF PHARMACOTHERAPY
- A Multinational Investigation of Time and Traveling Costs in Attending Anticoagulation Clinics
- (2007) Sue Jowett et al. VALUE IN HEALTH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search